A quality improvement project sought to improve pain management in patients undergoing radiation therapy for head and neck cancer.
The researchers found that the difference in time to obtain the result before and after the policy change was statistically significant.
Researchers explored early lymphopheresis for CD19-based chimeric antigen receptor T-cell therapy for relapsed/refractory DLBCL.
Surveillance of COVID-19 and COVID-19-associated mortality will continue after the expiration of the COVID-19 public health emergency declaration on May 11.
A nurse team compared the effectiveness of using a PBP with the Splashblocker device to reduce particle spread after flushing.
Researchers sought to determine whether CAR-T therapy would be a viable option for patients with relapsed/refractory large B-cell lymphoma.
Adding atezolizumab to standard treatment did not improve PFS in patients with advanced ovarian cancer and BRCA1/2 mutations or HRD.
Extended antibiotics do not reduce infection or reconstruction failure after postmastectomy breast reconstruction.
A psycho-educational program appeared to show improvements in spiritual well-being and quality of life for women with metastatic cancer.
Routine testing for ESR1 mutations should occur upon recurrence or progression of HR+, HER2- metastatic breast cancer, a guideline suggests.
Results of a real-world study suggest that early death may be common among cancer patients taking immune checkpoint inhibitors.
Significantly increased risk seen for any HPV-associated subsequent malignant neoplasms and oropharyngeal neoplasms.
Researchers sought to determine the effects of remote ischemic conditioning on cardiac biomarkers and function in patients treated with anthracyclines.
Researchers sought to determine whether combining nivolumab plus brentuximab vedotin would improve response rates in CAYAs with Hodgkin lymphoma.
Cancer death rates in the US have declined in recent years, but the declines vary by congressional district, a study suggests.